Alessia Santi

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial.

Journal: HemaSphere
Published: April 30, 2026

Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Journal: Science translational medicine
Published: February 04, 2026

Classic Hairy Cell Leukemia With MAP2K1 Mutation: Diagnosis and Targeted Therapy.

Classic Hairy Cell Leukemia With MAP2K1 Mutation: Diagnosis and Targeted Therapy.

Journal: American journal of hematology
Published: July 18, 2025

Independent Origin of Hairy Cell Leukemia (HCL) From Co-Occurring Clonal Hematopoiesis (CH).

Independent Origin of Hairy Cell Leukemia (HCL) From Co-Occurring Clonal Hematopoiesis (CH).

Journal: American journal of hematology
Published: May 12, 2025

Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.

Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.

Journal: The New England journal of medicine
Published: April 11, 2025

An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine.

An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine.

Journal: American journal of hematology
Published: August 28, 2023

Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia.

Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia.

Journal: The New England journal of medicine
Published: March 08, 2023

The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor.

The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor.

Journal: Leukemia
Published: October 04, 2022

Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.

Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.

Journal: British journal of haematology
Published: March 15, 2022

Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.

Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.

Journal: Blood cancer discovery
Published: June 24, 2021

Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial.

Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial.

Journal: Leukemia
Published: November 19, 2020

Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.

Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.

Journal: Blood
Published: November 06, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026